Orthofix is a leading medical device company and provider of spinal, orthopedic, bone growth, and motion preservation products since 1980.

Orthofix is the U.S. market leader with our PEMF technology bone growth stimulation systems, including various types of bone stimulators, indicated for post-operative spinal fusions and treating bone …

3 days ago · Orthofix posted Q4 2025 revenue growth, higher margins, reduced losses and strong free cash flow, underpinned by sustained expansion in Global Spine Fixation, Bone Growth Therapies …

3 days ago · Orthofix (OFIX) Q4 2025 earnings call recap: sales, EBITDA and free cash flow highlights plus 2026 guidance, risks and growth drivers—read now.

Orthofix is redefining postoperative care with advanced bone growth therapy devices built with surgeons and patients in mind. By blending clinical efficacy with ease of use, the company provides a safe, …

3 days ago · Orthofix saw single-digit growth in its fourth-quarter and full-year sales in 2025, according to financial results posted Feb. 24. Seven things to know: 1. Full-year sales were $822.3 million, …

Orthofix said the spinal fixation device, which is set to launch in late 2010, is locked in place without the use of a torque wrench, which simplifies the procedure for surgeons.

Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and …

4 days ago · Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2025, …

Headquartered in Lewisville, Texas, Orthofix delivers life-changing solutions to patients worldwide by providing advanced medical technologies and exceptional clinical support.